Jefferies Group LLC Cure Vac N.V. Transaction History

Jefferies Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$49.26 - $74.5 $199,995 - $302,470	-4,060 Closed	0 $0
Q2 2021 Sep 21, 2023	SELL	$56.91 - $127.53 $14,512 - $32,520	-255 Reduced 5.91%	4,060 $298,000
Q2 2021 Aug 16, 2021	BUY	$56.91 - $127.53 $231,054 - $517,771	4,060 New	4,060 $298,000
Q1 2021 May 14, 2021	SELL	$79.79 - $126.29 $344,293 - $544,941	-4,315 Closed	0 $0
Q4 2020 Sep 21, 2023	BUY	$46.76 - $136.27 $201,769 - $588,005	4,315 New	4,315 $349,000
Q4 2020 Feb 16, 2021	BUY	$46.76 - $136.27 $201,769 - $588,005	4,315 New	4,315 $350,000

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $514M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.